Cardinal Health Announces Governance Enhancements and Shareholder Value Creation Initiatives

Cardinal Health | September 07, 2022 | Read time : 06:00 min

Cardinal Health

Cardinal Health announced initiatives aimed at positioning the Company for long-term success, building on Cardinal Health's previously announced growth plans. These initiatives have benefited from input received from Elliott Investment Management L.P.  In connection with these initiatives, Elliott has also entered into a cooperation agreement with Cardinal Health, and Elliott's Steven Barg will join the Company's Board of Directors.

As part of Cardinal Health's ongoing commitment to Board refreshment and the initiatives announced today, the Governance and Sustainability Committee of the Board has recommended and the Board has approved the appointment of four new independent directors: Steven Barg, Michelle Brennan, Sujatha Chandrasekaran and Christine Mundkur. With these immediate appointments, Cardinal Health's Board will be made up of 15 Directors, 14 of whom are independent under the Company's director independence standards. Two existing Directors – Dean Scarborough and John Weiland – have announced their intentions to conclude their Board service at the end of their previously elected terms this fall and will not stand for re-election at Cardinal Health's 2022 Annual Meeting, resulting in a 13-member Board.  Following the Annual Meeting, Cardinal Health's Board will consist of 54% women and 23% racially or ethnically diverse individuals.

Cardinal Health's Board has also formed a new Board committee, the Business Review Committee, to support a comprehensive review of the Company's strategy, portfolio, capital-allocation framework, and operations with the goal of maximizing Cardinal Health's potential for the benefit of all stakeholders. The Business Review Committee will be chaired by Chief Executive Officer Jason Hollar; Mr. Barg and Akhil Johri will also serve on the Committee. The Committee, with the assistance of the Company's legal and financial advisors, will make recommendations to the full Board. The Company expects to conduct an investor day in the first half of calendar 2023 to share the Board's conclusions and to provide additional guidance.  

"We'd like to thank Dean and John for their service to the Board. We're grateful for their leadership and contributions and wish them both the very best. We're pleased to welcome Steven, Michelle, Sujatha and Christine to the Board and believe the Company and our many stakeholders will benefit from their mix of experience, skills and leadership. We are also pleased with Elliott's confidence in, and commitment to, the go-forward long-term potential of Cardinal Health. Our Board looks forward to receiving the recommendations of the Business Review Committee and updating the market in due course, as Jason and his leadership team chart a path to deliver upon our mission for our customers and employees and drive value creation for our shareholders."

Gregory Kenny, Independent Chairman of the Board of Cardinal Health

"Cardinal Health's leadership team is focused on creating value for all our stakeholders, and the newly initiated Business Review Committee, as well as the new expertise and experience being added to our Board, are critical steps in this process," said Mr. Hollar, Cardinal Health's Chief Executive Officer. "I look forward to working with the Board, including our four new directors, to optimize our strategy, structure, and operations as we position Cardinal Health for long-term success."

Elliott Senior Portfolio Manager Marc Steinberg said, "Our discussions with Jason and the Board have been positive and productive, and we are pleased to have worked collaboratively to reach this agreement. Cardinal Health plays a mission-critical, market-leading role in the global healthcare system, and we have been encouraged by the Company's openness to taking actions necessary to ensuring that Cardinal Health realizes its full potential. We are confident that the initiatives announced today will drive meaningful shareholder value creation, and we look forward to continuing our collaboration with the Company."

Michelle Brennan is Chair of Connect Healthcare Council for Pioneering Collective and serves on the Board of Coupa Software. Ms. Brennan spent more than 30 years at Johnson & Johnson, a leader in the field of medical devices, pharmaceutical, and consumer packaged goods, where she focused on driving growth, optimization and business transformation across diverse businesses and geographies. Most recently, Ms. Brennan served as the Global Value Creation Leader for Johnson & Johnson and as a member of the company's Medical Device Executive Leadership Team responsible for the division's value creation through cost management initiatives. Prior to that, Ms. Brennan held a number of positions at Johnson & Johnson, including Company Group Chair, Medical Devices (EMEA); President, Enterprise Standards & Productivity; Worldwide President, Ethicon Energy; as well as a variety of sales and marketing positions for other Johnson & Johnson divisions. Throughout her time at Johnson & Johnson, Ms. Brennan held significant board roles for the company, including Chairman of the Board for Medtech Europe Trading Association. She was previously a member of the UK's Office of Life Sciences Council and Chairman of the Council's Health Technology Partnership Committee.

Ms. Brennan holds a B.S. from the University of Kansas.

Sujatha Chandrasekaran, also known as Suja, is an advisor and independent consultant in the research and technology sectors. She currently serves on the Board of American Eagle Outfitters as well as private companies including Agendia, a molecular diagnostics company, and Blume Global, a digital supply chain platform company. Ms. Chandrasekaran has more than 25 years of experience in technology and leadership roles across the healthcare, consumer packaged goods and retail industries. Most recently, Ms. Chandrasekaran was Senior EVP & Chief Digital and Information Officer at CommonSpirit Health, one of the largest non-profit health systems in the US. Prior to that, she held a number of senior executive roles at several Fortune 500 multinational companies, including Global Chief Information Officer for Kimberly-Clark; SVP, Global Chief Technology and Data Officer for Walmart; as well as a number of C-level roles at The Timberland Company, PepsiCo and Nestlé SA. Ms. Chandrasekaran has a strong track record of delivering significant value to customers and organizations by leading global technology, supply chain and digital transformation initiatives. In 2022, Ms. Chandrasekaran was recognized by Modern Healthcare as one of the Top 25 Women Leaders in Healthcare. She was previously a Director of Symphony Technology Group and a Director of Barry Callebaut AG as well as a Member of Advisory Board at Atmio Inc. 

Ms. Chandrasekaran holds an Executive Development Education Certificate from London Business School; a Master of Business Systems/M.B.A. from Monash University in Melbourne, Australia; and a B.Eng. from the University of Madras, India.

Christine Mundkur most recently served as Chief Executive Officer and Non-Voting Chairman of the Board of Directors for Impopharma Inc, a developer of complex formulations focused on inhalation pharmaceutical products. Ms. Mundkur currently serves on the Boards of Lupin Limited and MannKind Corporation. While at Impopharma, she led the transition of the company from a successful clinical research organization into a generic pharmaceutical inhalation development company. She also held leadership positions as President and Chief Executive Officer for North America for Sandoz, Inc. Earlier, she served as Chief Executive Officer of Barr Laboratories, Inc. Ms. Mundkur started her career at Barr as quality and regulatory counsel. In addition, she served as a strategic advisor to clients on generics, 505(b)2, biosimilars and NDA business strategies.

Ms. Mundkur holds a J.D. from the St. Louis University School of Law and a B.S. from St. Louis University.

About Cardinal Health
Cardinal Health is a distributor of pharmaceuticals, a global manufacturer and distributor of medical and laboratory products, and a provider of performance and data solutions for health care facilities. With 50 years in business, operations in more than 30 countries and approximately 44,000 employees globally, Cardinal Health is essential to care. 


Operating rules support a range of standards to make electronic data transactions more predictable and consistent, regardless of the technology.


Operating rules support a range of standards to make electronic data transactions more predictable and consistent, regardless of the technology.

Related News


Kognitiv launches Powerful News AI-Driven Kognitiv Pulse

prnewswire | March 29, 2023

Technology company Kognitiv Corporation delivers advanced loyalty management, data activation and partner collaboration solutions to enable data-driven personalization and optimization of the customer journey across its innovative, omnichannel SaaS platform. Next week, Kognitiv is excited to officially launch a new AI-driven predictive customer insights and activation tool, Kognitiv Pulse, a solution that monitors the health of your customer base, predicts future behaviour and identifies risks and opportunities while enabling you to act quickly on these insights. Anchored on Kognitiv's proprietary SmartJourney® customer lifecycle methodology, Kognitiv Pulse is powered by proprietary artificial intelligence and machine learning software. It enables marketers to drive efficiencies by identifying – at an individual level - which customers to engage proactively and helps them focus on activities that grow their bottom line. "This tool is exciting because it allows you to see, side-by-side, how your loyalty and non-loyalty customers are performing across key KPIs, like purchase frequency and customer lifetime value," said Anthony Wintheiser, chief product officer at Kognitiv. "It then predicts which milestone they're likely to be in next and prescribes what actions you should take next in order to keep them engaged and growing in their relationship with your brand." Previewed through a live demo to a global audience of customer engagement and loyalty experts at the Loyalty Summit CXM conference in Zurich, Switzerland, on March 16, 2023, through a live demo of the product, Kognitiv Pulse was well-received by the crowd of attendees and retail leaders like Kognitiv client PetSmart. Kognitiv's global roster of clients includes leading brands like Hallmark, Avis, Hawaiian Airlines. "We want to arm marketers with the metrics and reporting they need to not only make better decisions about how and when to engage their customers, but also to measure how those decisions are driving revenue growth," said Tim Sullivan, CEO of Kognitiv. "As an executive and former marketer, I know firsthand how valuable this product is to decision making, strategic planning and profitable revenue growth. I believe adding this revolutionary product to our arsenal will help propel Kognitiv to the levels of growth and profitability that I envisioned when I joined the firm." About Kognitiv Founded in 2008, Kognitiv is challenging global brands to redefine how they engage with their customers and deliver meaningful experiences that earn their lifetime loyalty. In June 2020, Kognitiv and Aimia's Loyalty Solutions came together to create a data and technology-led business, employing people across 20 countries worldwide. With 200+ clients and partners in more than 50 markets globally, Kognitiv is removing the complexity of cultivating loyalty, data, and partnerships, so brands can deliver enhanced value, personalization, and experiences to today's consumers, right where they are. Kognitiv's largest investors include Aimia Inc., a publicly-traded holding company listed on the Toronto Stock Exchange.

Read More


Innovive Health Expands Groundbreaking Home Healthcare Model and Services to Colorado

Businesswire | April 26, 2023

Innovive Health, a data-driven home health care agency serving complex behavioral health patients, announced that it is expanding its groundbreaking behavioral health home care model to Colorado. The expansion comes as the nation’s health care system is facing a growing patient population with behavioral health needs and unprecedented staffing and economic pressures in the wake of the pandemic. Building on the agency’s growing operations in Massachusetts, which currently cares for more than 20,000 patient visits each week across the state, Innovive Health has acquired a license to operate in Colorado. “Nationally, there has never been a time when the need for mental health services in home or community settings have been more paramount. This expansion to Colorado not only helps meet this growing need, but also validates our innovative care model,” said Joseph McDonough, Founder and CEO of Innovive Health. “Our dedicated team of caregivers is proud to bring our model of care to Colorado and to care for patients where they need it most – in the safety of their homes and not in the emergency department." Operating out of Colorado Springs, Innovive Health already has a small staff of nurses on board who have begun seeing patients. Innovive Health’s unique home health model focuses on patients who have multiple medical comorbidities with complicating behavioral illness, treating and educating patients on their holistic well-being. With a deep understanding of the dynamics of the evolving data-driven healthcare market along with a proven track record of adopting new technologies – such as a cloud-based infrastructure and a fully integrated EMR – Innovive Health is well positioned to rapidly scale its services in new markets such as Colorado. “We are pleased to start operations in Colorado, which has demonstrated the state’s dedication to increasing access to care for behavioral health patients by earmarking $547 million to behavioral health projects for Coloradans,” said Nicholas D’Addabbo, Vice President of Strategy of Innovive Health. “With over 82,000 outpatient behavioral health visits in Colorado Springs in 2019 and more than 18 percent of Colorado Springs adults reporting having experienced a behavioral health disorder in the last year, increasing access to home and community-based supports for patients with comorbid behavioral and physical illness is imperative.” Since its inception in 2004, Innovive Health has played a vital role as the hub for a complex care team – coordinating with a multitude of specialists and providers across the continuum of care. For nearly two decades, the innovative home healthcare agency has built a strong clinical and operations team while establishing and expanding the company’s partnerships with healthcare organizations and world-class technology companies to fundamentally change the way care is delivered to this population. Innovive Health provides skilled nursing services in the home with specialty programs to assist in the overall treatment and management of comorbid disease processes. “Based on our track record serving some of Massachusetts most vulnerable behavioral health patients, I’ve seen how home healthcare can remove the social barriers to continuing care and reduce unnecessary utilization of high-cost ED and hospital visits,” added McDonough. “Our complex behavioral health patients have at least one severe mental health diagnosis with an average of 10-12 medical comorbidities – they also take up to 10-15 medications and often live in communities with less access to care. Given our experience with this patient population, we are well positioned to have an immediate impact in treating similar patients in Colorado, which will help deliver better patient outcomes while taking pressure off the healthcare system.” About Innovive Health With operations in Massachusetts and Colorado, Innovive Health is one of the nation’s fastest growing home healthcare agencies focused on serving complex behavioral health patients. Innovive Health has been delivering strong clinical outcomes for nearly two decades and is transforming healthcare through an innovative model of patient-centered, data driven, full-service home care. The agency provides high quality nursing and services to some of the nation’s most vulnerable and underserved populations in the safety and comfort of their homes and communities.

Read More


Streamline Unveils New Brand for Company, SmartCare™ Behavioral Health EHR

Businesswire | May 02, 2023

Streamline Healthcare Solutions, a leading provider of Electronic Health Record (EHR) solutions to the Behavioral Health market, today unveiled its new brand for the company and its SmartCare™ EHR platform as part of its 20th Anniversary celebrations. “We can’t think of a better way to celebrate 20 years than by unveiling a new brand, one that captures the essence of all we’ve learned over two decades in behavioral health and how that informs our mission of empowering behavioral health professionals to advance the lives of those in need,” said Streamline Co-Founder and CEO Javed Husain. Streamline was founded in 2003 by Javed Husain and David Ryland. The company’s SmartCare™ EHR platform sets a new standard for Behavioral Health EHRs. Its dependability and stability provide organizations with the control they need to succeed in today’s complex environment, while its flexibility enables them to transform the way they provide care to meet the exciting promise of tomorrow. “People choose to work in behavioral health out of a deep desire to help others weather life’s storms. We partner with our customers to provide innovative technology solutions that help them achieve this goal,” Husain said. About Streamline and SmartCare™ Since 2003, Streamline has focused exclusively on the Behavioral Health market. Understanding that organizations in this market need more than just another Electronic Health Record (EHR) vendor, the company is a trusted partner in building innovative technology solutions that empower people to improve the quality of life for those in need. SmartCare™ is a true enterprise solution built on a stable, single platform with robust analytics so organizations and users alike have the control they need to operate more efficiently and provide care more effectively. The platform’s individualized, intuitive and intelligent design provides users with the flexibility not just to adapt to today’s challenges but to transform the way they provide care in the future.

Read More